Duncan McKechnie
EVP, Chief Commercial Officer · VERTEX PHARMACEUTICALS INC / MA
- 2026
- Jul 7, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Duncan McKechnie files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Amit Sachdev - $28.38M in VRTX purchases and sales in the last 12 months
- Reshma Kewalramani - $19.74M in VRTX purchases and sales in the last 12 months
- Carmen Bozic - $11.31M in VRTX purchases and sales in the last 12 months
- Charles F. Wagner Jr. - $6.38M in VRTX purchases and sales in the last 12 months
- Ourania Tatsis - $4.38M in VRTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Duncan McKechnie?
Duncan McKechnie is a corporate insider, tracked as EVP, Chief Commercial Officer of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Duncan McKechnie last file a Form 4?
The most recent primary Form 4 on record is dated 7 July 2026, one of 8 filings going back to 2026.
Has Duncan McKechnie been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($5.66M) across all tracked filings.
